If you have lost money in the stock market due to fraud, misrepresentation, negligence, or for other reasons, we can help you. We have successfully recovered over $250 million in FINRA securities arbitrations.*
Need Legal Help? Contact Us. Call +1 (888) 997-9956
KlaymanToskes, www.klaymantoskes.com, announced today that it is investigating damages sustained by current and former employees and investors of MGM Resorts International (NYSE:MGM) (“MGM”) who held large, unhedged concentrated positions in MGM stock and/or received margin calls resulting in the forced sale of stock. The recent losses were the result of unsuitable advice during the Coronavirus (“COVID-19”) pandemic. The investigation focuses on full-service brokerage firms’ negligence and failure to supervise the management of concentrated, leveraged positions in MGM stock.
Investment portfolios holding large, concentrated stock positions carry significant downside risks, especially when leveraged by a margin loan. Full-service brokerage firms whose customers hold large concentrated stock positions have a duty to ensure that their customers understand the risks associated with concentration and to disclose and recommend the availability of risk management strategies. The failure to use risk management strategies as well as the failure to “hedge” the value of a concentrated portfolio directly exposes an investor’s concentrated position to fluctuations in the volatile securities markets. Since trading as high as 34.64 per share in January 2020, the price of MGM stock dropped to 5.90 on March 18, 2020, a decline of nearly 83%.
The sole purpose of this release is to investigate whether strategies deployed by full-service brokerage firms were suitable for MGM employees and investors with concentrated, leveraged stock positions. MGM shareholders who held accounts at full-service brokerage firms, and have information relating to the manner in which the firm handled their concentrated, leveraged portfolios, are encouraged to contact Lawrence L. Klayman, Esq., at (561) 542-5131, and download our Special Investor Report.